Cancer Therapy News and Research

RSS

New accelerator-based technology aims to reduce side effects of cancer radiation therapy

New accelerator-based technology being developed by the Department of Energy's SLAC National Accelerator Laboratory and Stanford University aims to reduce the side effects of cancer radiation therapy by shrinking its duration from minutes to under a second.

29 Nov 2018

Researchers examine the experiences of veterans receiving both cancer treatment and hospice care

Veterans Health Administration hospitals offer something Medicare does not: In some cases, treatments meant to alter the course of a disease can be offered along with hospice care.

28 Nov 2018

New therapeutic drug monitoring service could benefit children with cancer

Children with cancer are to benefit nationally from a service which for the first time will allow doctors to personalize their treatment.

28 Nov 2018

Research may pave way for development of potent weapons against cancer

Despite significant advances in cancer research, the disease continues to exact a devastating toll. Because cancer is a disease of the body's own cells, which mutate and develop under evolutionary pressure, conventional treatments like chemotherapy and radiation often leave behind a residue of resistant cells that go on to expand and wreak havoc.

27 Nov 2018

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia

Some severe forms of leukemia develop because proteins on the epigenetic level lose their regulative function. Now, in a broad international collaboration, UK researchers have identified molecules that can effectively inhibit the dysregulated proteins.

27 Nov 2018

Citrate-based biomaterial could help in better bone repair

A material based on a natural product of bones and citrus fruit, called citrate, provides the extra energy that stem cells need to form new bone tissue, according to a team of Penn State bioengineers.

27 Nov 2018

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

The U.S. Food and Drug Administration today granted accelerated approval to Vitrakvi (larotrectinib), a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker).

27 Nov 2018

Biological aging caused by cancer treatments correlates with cognitive decline

Cancer treatments are suspected to accelerate certain aging processes in the body. A new study has found that indicators of such biological aging correlate with declines in cognitive function in women who had undergone breast cancer treatment several years earlier.

26 Nov 2018

Japan-India collaboration results in new treatment approach for male urethral stricture

A novel and relatively pain-less treatment method for male urethral stricture using patients own buccal mucosal cells has been reported as successful in four out of six patients.

25 Nov 2018

Novel DNA nanoplatform delivers anticancer agents to multidrug-resistant tumors

One of the most successful techniques to combat multidrug resistance in cancer cells is the downregulation of those genes responsible for drug resistance.

22 Nov 2018

Nutritional supplement can slow cancer growth and enhance effects of chemotherapy

Mannose sugar, a nutritional supplement, can both slow tumor growth and enhance the effects of chemotherapy in mice with multiple types of cancer.

21 Nov 2018

Sugar supplement shown to slow tumor growth and enhance chemotherapy

Mannose, a type of sugar, has been shown to slow tumor growth and enhance chemotherapy in mouse models of certain cancers.

21 Nov 2018

Researchers awarded $7 million funding in Pancreatic Cancer Collective’s 'New Therapies Challenge'

The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer, has awarded a total of $7 million in first-round "New Therapies Challenge" grants to seven teams of top cancer researchers to explore new pancreatic cancer treatments, the American Association for Cancer Research, the Scientific Partner of SU2C, announced today.

21 Nov 2018

Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

The Abramson Cancer Center (ACC) at the University of Pennsylvania announced today that it is joining the National Comprehensive Cancer Network (NCCN) as its 28th member institution.

20 Nov 2018

New solution to stop spread of brain cancer

The tissues in our bodies largely are made of fluid. It moves around cells and is essential to normal body function.

19 Nov 2018

Researchers develop novel mouse model to study immunomodulatory therapies

Because mice do not respond to immunomodulatory drugs, preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice.

19 Nov 2018

Personalized scheduling of radiotherapy using genetic data could reduce side effects

A new clinical study led by the University of Leicester and conducted in the HOPE clinical trials facility at Leicester's Hospitals has revealed the pivotal role that changing the time of day that a patient receives radiotherapy could play in altering radiotherapy toxicity.

16 Nov 2018

NIH awards over $1.8 million to husband-and-wife doctors to test new breast cancer approach

Husband-and-wife doctors at the University of Virginia Cancer Center have been awarded more than $1.8 million from the National Institutes of Health for their effort to improve radiation therapy and breast surgery for patients with early-stage breast cancer.

16 Nov 2018

Specific bacterial toxins reduce number of cells suppressing immune response

Staphylococcus aureus bacteria can cause numerous diseases, such as skin infections, pneumonia and blood poisoning.

16 Nov 2018

Two genomic tests help identify most effective treatment for breast cancer patients

New results from a long-running trial to identify which new drugs or combinations of drugs are most effective in which types of breast cancer, show that two genomic tests are bringing the era of truly personalized medicine ever nearer.

14 Nov 2018

Cancer Therapy News and Research

New accelerator-based technology aims to reduce side effects of cancer radiation therapy

Researchers examine the experiences of veterans receiving both cancer treatment and hospice care

New therapeutic drug monitoring service could benefit children with cancer

Research may pave way for development of potent weapons against cancer

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia

Citrate-based biomaterial could help in better bone repair

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

Biological aging caused by cancer treatments correlates with cognitive decline

Japan-India collaboration results in new treatment approach for male urethral stricture

Novel DNA nanoplatform delivers anticancer agents to multidrug-resistant tumors

Nutritional supplement can slow cancer growth and enhance effects of chemotherapy

Sugar supplement shown to slow tumor growth and enhance chemotherapy

Researchers awarded $7 million funding in Pancreatic Cancer Collective’s 'New Therapies Challenge'

Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

New solution to stop spread of brain cancer

Researchers develop novel mouse model to study immunomodulatory therapies

Personalized scheduling of radiotherapy using genetic data could reduce side effects

NIH awards over $1.8 million to husband-and-wife doctors to test new breast cancer approach

Specific bacterial toxins reduce number of cells suppressing immune response

Two genomic tests help identify most effective treatment for breast cancer patients

Your guide to microplate readers for cancer research eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News